Nobuyo Maeda

Active 1984–2020

99
Papers
21,706
Citations
82
h-index
98
i10-index

Citations

Citations per year for Nobuyo Maeda1983: 1 citations1985: 5 citations1986: 3 citations1987: 5 citations1988: 19 citations1989: 23 citations1990: 22 citations1991: 17 citations1992: 20 citations1993: 30 citations1994: 38 citations1995: 39 citations1996: 40 citations1997: 73 citations1998: 138 citations1999: 146 citations2000: 244 citations2001: 282 citations2002: 245 citations2003: 275 citations2004: 311 citations2005: 306 citations2006: 316 citations2007: 265 citations2008: 262 citations2009: 273 citations2010: 302 citations2011: 245 citations2012: 240 citations2013: 215 citations2014: 196 citations2015: 205 citations2016: 167 citations2017: 145 citations2018: 145 citations2019: 422 citations2020: 473 citations2021: 375 citations2022: 311 citations2023: 150 citations2024: 250 citations2025: 112 citations2026: 1 citations1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,461 citing papers, 37.3% of this breakdownChina: 593 citing papers, 6.4% of this breakdownUnited Kingdom: 584 citing papers, 6.3% of this breakdownGermany: 547 citing papers, 5.9% of this breakdownJapan: 451 citing papers, 4.9% of this breakdownCanada: 415 citing papers, 4.5% of this breakdownNetherlands: 347 citing papers, 3.7% of this breakdownFrance: 330 citing papers, 3.6% of this breakdownItaly: 262 citing papers, 2.8% of this breakdownAustralia: 254 citing papers, 2.7% of this breakdownSweden: 173 citing papers, 1.9% of this breakdownSwitzerland: 169 citing papers, 1.8% of this breakdown
0%37.3%Other 18.2%

Fields

  • Medicine52%
  • Biochemistry, Genetics and Molecular Biology27.2%
  • Immunology and Microbiology12.1%
  • Neuroscience3.9%
  • Nursing2.4%
  • Agricultural and Biological Sciences0.5%
  • Other1.9%

Topics

  • Cholesterol and Lipid Metabolism3.5%
  • Atherosclerosis and Cardiovascular Diseases3%
  • Peroxisome Proliferator-Activated Receptors2.8%
  • Liver Disease Diagnosis and Treatment2%
  • Drug Transport and Resistance Mechanisms1.8%
  • Alzheimer's disease research and treatments1.8%
  • Other85.1%

Coauthors

All papers

Open in search
  1. Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E

    Authors: , , , - Science 1992 cited by 2,240

  2. Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis

    Authors: , , , , , , , - Journal of Biological Chemistry 1997 cited by 597

  3. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nobuyo Maeda, Siamon Gordon, Tatsuhiko Kodama - Nature 1997 cited by 1,221

  4. Apolipoprotein E–low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner

    Authors: , , , , , , , - Neurobiology of Disease 2014 cited by 111

  5. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†

    Authors: , , , , , , , , , , , , - Hepatology 2008 cited by 467

  6. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2001 cited by 705

  7. Contrasting Effects of CCR5 and CCR2 Deficiency in the Pulmonary Inflammatory Response to Influenza A Virus

    Authors: , , , , - American Journal Of Pathology 2000 cited by 384

  8. Increased Cellular Free Cholesterol in Macrophage-specific Abca1 Knock-out Mice Enhances Pro-inflammatory Response of Macrophages

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2008 cited by 360

  9. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells

    Authors: , , , , , , - Nature 1987 cited by 794

  10. Apo E structure determines VLDL clearance and atherosclerosis risk in mice

    Authors: , , , , , , , - Journal of Clinical Investigation 1999 cited by 344

  11. Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in Mice

    Authors: , , , , , , , - Journal of Biological Chemistry 2003 cited by 336

  12. Aortic wall damage in mice unable to synthesize ascorbic acid

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 260

  13. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond

    Authors: , , , , - Journal of Lipid Research 2008 cited by 158

  14. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

    Authors: , , , , , , , , - Journal of Clinical Investigation 2002 cited by 1,004

  15. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection Rapid Communication

    Authors: , , , , , , , - Kidney International 2004 cited by 314

  16. The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system

    Authors: , , , , - Journal of Neuroimmunology 2000 cited by 168

  17. New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis

    Authors: , , , , , , , , , , , , - Vascular Pharmacology 2020 cited by 35

  18. Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene

    Authors: , , , , , , , , , , - Journal of Biological Chemistry 1996 cited by 272

  19. Loss of TIMP3 Enhances Interstitial Nephritis and Fibrosis

    Authors: , , , , , , , , - Journal of the American Society of Nephrology 2009 cited by 141

  20. Proteolysis of the low density lipoprotein receptor by bone morphogenetic protein-1 regulates cellular cholesterol uptake

    Authors: , , , , , , , , , - Scientific Reports 2019 cited by 25

  21. Severe Impairment in Early Host Defense againstCandida albicansin Mice Deficient in Myeloperoxidase

    Authors: , , , , , - Infection and Immunity 1999 cited by 311

  22. Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment

    Authors: , , , , , - Journal of Clinical Investigation 2000 cited by 302

  23. Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice

    Authors: , , , , , - Journal of Clinical Investigation 2001 cited by 219

  24. Genetic Modifiers of Atherosclerosis in Mice

    Authors: , - Arteriosclerosis Thrombosis and Vascular Biology 2000 cited by 164